Your browser doesn't support javascript.
loading
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
Giannella, Maddalena; Freire, Maristela; Rinaldi, Matteo; Abdala, Edson; Rubin, Arianna; Mularoni, Alessandra; Gruttadauria, Salvatore; Grossi, Paolo; Shbaklo, Nour; Tandoi, Francesco; Ferrarese, Alberto; Burra, Patrizia; Fernandes, Ruan; Aranha Camargo, Luis Fernando; Asensio, Angel; Alagna, Laura; Bandera, Alessandra; Simkins, Jacques; Abbo, Lilian; Halpern, Marcia; Santana Girao, Evelyne; Valerio, Maricela; Muñoz, Patricia; Fernandez Yunquera, Ainhoa; Statlender, Liran; Yahav, Dafna; Franceschini, Erica; Graziano, Elena; Morelli, Maria Cristina; Cescon, Matteo; Viale, Pierluigi; Lewis, Russell.
Afiliação
  • Giannella M; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Freire M; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Rinaldi M; Working Committee for Hospital Epidemiology and Infection Control, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
  • Abdala E; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Rubin A; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Mularoni A; Infectious Diseases Department, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
  • Gruttadauria S; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Grossi P; Infectious Diseases, ISMETT IRCCS, Palermo, Italy.
  • Shbaklo N; Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS, ISMETT-UPMC, Palermo, Italy.
  • Tandoi F; Infectious and Tropical Diseases Department, University of Insubria, Varese, Italy.
  • Ferrarese A; Infectious Disease, Department of Medical Sciences University of Turin AOU Città della salute e della Scienza, Turin, Italy.
  • Burra P; Liver Transplant Center, General Surgery Unit, Department of Surgical Sciences, AOU Città della Salute e della Scienza, Molinette Hospital, University of Turin, Turin, Italy.
  • Fernandes R; Multivisceral Transplant Unit (Gastroenterology), Department of Surgery Oncology and Gastroenterology, Surgical and Gastroenterological Sciences, Padua University Hospital, Padua, Italy.
  • Aranha Camargo LF; Multivisceral Transplant Unit (Gastroenterology), Department of Surgery Oncology and Gastroenterology, Surgical and Gastroenterological Sciences, Padua University Hospital, Padua, Italy.
  • Asensio A; Infectious Diseases Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Alagna L; Infectious Diseases Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Bandera A; Preventive Medicine Department, Puerta de Hierro-Majadahonda University Hospital, Majadahonda, Madrid, Spain.
  • Simkins J; Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Abbo L; Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Halpern M; Transplant Infectious Diseases and Immunocompromised Host Service, Division of Infectious Diseases, University of Miami/Miami Transplant Institute, Miami, Florida, USA.
  • Santana Girao E; Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, Florida, USA.
  • Valerio M; Liver Transplant Unit, Quinta D'Or Hospital, Rio de Janeiro, Brazil.
  • Muñoz P; Infectious Diseases Unit and Liver Transplant Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará, Fortaleza, Brazil.
  • Fernandez Yunquera A; Department of Clinical Microbiology and Infectious Diseases, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Statlender L; Department of Clinical Microbiology and Infectious Diseases, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Yahav D; Department of Gastroenterology, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Franceschini E; Intensive Care Unit, Rabin Medical Center, Petah Tikva, Israel.
  • Graziano E; Infectious Disease Unit, Beilinson Hospital, Petah Tikva, Israel.
  • Morelli MC; Infectious Diseases Unit, Department of Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.
  • Cescon M; Infectious Disease Clinic, ASUFC, Udine, Italy.
  • Viale P; Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Lewis R; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Clin Infect Dis ; 73(4): e955-e966, 2021 08 16.
Article em En | MEDLINE | ID: mdl-33564840
BACKGROUND: Patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) are at higher risk of developing CRE infection after liver transplantation (LT), with associated high morbidity and mortality. Prediction model for CRE infection after LT among carriers could be useful to target preventive strategies. METHODS: Multinational multicenter cohort study of consecutive adult patients underwent LT and colonized with CRE before or after LT, from January 2010 to December 2017. Risk factors for CRE infection were analyzed by univariate analysis and by Fine-Gray subdistribution hazard model, with death as competing event. A nomogram to predict 30- and 60-day CRE infection risk was created. RESULTS: A total of 840 LT recipients found to be colonized with CRE before (n = 203) or after (n = 637) LT were enrolled. CRE infection was diagnosed in 250 (29.7%) patients within 19 (interquartile range [IQR], 9-42) days after LT. Pre- and post-LT colonization, multisite post-LT colonization, prolonged mechanical ventilation, acute renal injury, and surgical reintervention were retained in the prediction model. Median 30- and 60-day predicted risk was 15% (IQR, 11-24) and 21% (IQR, 15-33), respectively. Discrimination and prediction accuracy for CRE infection was acceptable on derivation (area under the curve [AUC], 74.6; Brier index, 16.3) and bootstrapped validation dataset (AUC, 73.9; Brier index, 16.6). Decision-curve analysis suggested net benefit of model-directed intervention over default strategies (treat all, treat none) when CRE infection probability exceeded 10%. The risk prediction model is freely available as mobile application at https://idbologna.shinyapps.io/CREPostOLTPredictionModel/. CONCLUSIONS: Our clinical prediction tool could enable better targeting interventions for CRE infection after transplant.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Infecções por Enterobacteriaceae / Enterobacteriáceas Resistentes a Carbapenêmicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Infecções por Enterobacteriaceae / Enterobacteriáceas Resistentes a Carbapenêmicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article